Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank87
3Y CAGR+41.5%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+41.5%/yr
Annual compound
Percentile
P87
Within normal range
vs 3Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.77M-31.9%
2024$4.07M+19.9%
2023$3.39M+247.0%
2022$978000.00+676.2%
2021$126000.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-